115 related articles for article (PubMed ID: 8863536)
1. Investigation of myelin/oligodendrocyte glycoprotein membrane topology.
Kroepfl JF; Viise LR; Charron AJ; Linington C; Gardinier MV
J Neurochem; 1996 Nov; 67(5):2219-22. PubMed ID: 8863536
[TBL] [Abstract][Full Text] [Related]
2. Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice.
Ballenthin PA; Gardinier MV
J Neurosci Res; 1996 Oct; 46(2):271-81. PubMed ID: 8915905
[TBL] [Abstract][Full Text] [Related]
3. Membrane topology of the myelin/oligodendrocyte glycoprotein.
della Gaspera B; Pham-Dinh D; Roussel G; Nussbaum JL; Dautigny A
Eur J Biochem; 1998 Dec; 258(2):478-84. PubMed ID: 9874214
[TBL] [Abstract][Full Text] [Related]
4. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily.
Gardinier MV; Matthieu JM
Schweiz Arch Neurol Psychiatr (1985); 1993; 144(3):201-7. PubMed ID: 7687365
[TBL] [Abstract][Full Text] [Related]
5. Identification of a basolateral membrane targeting signal within the cytoplasmic domain of myelin/oligodendrocyte glycoprotein.
Kroepfl JF; Gardinier MV
J Neurochem; 2001 Jun; 77(5):1301-9. PubMed ID: 11389181
[TBL] [Abstract][Full Text] [Related]
6. Mutually exclusive apicobasolateral sorting of two oligodendroglial membrane proteins, proteolipid protein and myelin/oligodendrocyte glycoprotein, in Madin-Darby canine kidney cells.
Kroepfl JF; Gardinier MV
J Neurosci Res; 2001 Dec; 66(6):1140-8. PubMed ID: 11746447
[TBL] [Abstract][Full Text] [Related]
7. [Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders].
Chekhonin VP; Semenova AV; Gurina OI; Dmitrieva TB
Biomed Khim; 2003; 49(5):411-23. PubMed ID: 16119093
[TBL] [Abstract][Full Text] [Related]
8. The role of N-glycan in folding, trafficking and pathogenicity of myelin oligodendrocyte glycoprotein (MOG).
Jung J; Dudek E; Michalak M
Biochim Biophys Acta; 2015 Sep; 1853(9):2115-21. PubMed ID: 25541284
[TBL] [Abstract][Full Text] [Related]
9. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily.
Gardinier MV; Amiguet P; Linington C; Matthieu JM
J Neurosci Res; 1992 Sep; 33(1):177-87. PubMed ID: 1453482
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets.
Dyer CA; Matthieu JM
J Neurochem; 1994 Feb; 62(2):777-87. PubMed ID: 7507516
[TBL] [Abstract][Full Text] [Related]
11. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein.
Hilton AA; Slavin AJ; Hilton DJ; Bernard CC
J Neurochem; 1995 Jul; 65(1):309-18. PubMed ID: 7790876
[TBL] [Abstract][Full Text] [Related]
13. A molecular model of myelin oligodendrocyte glycoprotein.
Hjelmström P; Penzotti JE; Henne RM; Lybrand TP
J Neurochem; 1998 Oct; 71(4):1742-9. PubMed ID: 9751210
[TBL] [Abstract][Full Text] [Related]
14. Structure of the human myelin/oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms.
Pham-Dinh D; Della Gaspera B; Kerlero de Rosbo N; Dautigny A
Genomics; 1995 Sep; 29(2):345-52. PubMed ID: 8666381
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
17. An antisense transgenic strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis.
Jaquet V; Gow A; Tosic M; Suchanek G; Breitschopf H; Lassmann H; Lazzarini RA; Matthieu JM
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):333-7. PubMed ID: 9037550
[TBL] [Abstract][Full Text] [Related]
18. Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition.
Solly SK; Thomas JL; Monge M; Demerens C; Lubetzki C; Gardinier MV; Matthieu JM; Zalc B
Glia; 1996 Sep; 18(1):39-48. PubMed ID: 8891690
[TBL] [Abstract][Full Text] [Related]
19. A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55.
Albouz-Abo S; Wilson JC; Bernard CC; von Itzstein M
Eur J Biochem; 1997 May; 246(1):59-70. PubMed ID: 9210466
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
